Paclitaxel 100 mg Injection is an antineoplastic medicine containing paclitaxel, a taxane-class compound used in the management of several types of cancer. It works by interfering with the normal function of microtubules, which are essential for cell division, thereby helping inhibit the growth and multiplication of cancer cells.
Aliyan Pharmaceuticals offers Paclitaxel 100 mg Injection as part of its oncology pharmaceutical portfolio for institutional, distributor, and international pharmaceutical supply requirements. As an established pharmaceutical manufacturer in India, the company supports businesses looking for reliable paclitaxel 100 mg injection suppliers, paclitaxel 100 mg injection manufacturers, and export-oriented pharmaceutical sourcing partners.
The product is manufactured under controlled pharmaceutical processes with attention to quality, consistency, packaging, and regulatory requirements. Availability, presentations, and documentation can be aligned with applicable market requirements and customer specifications.
Paclitaxel 100 mg Injection Uses
Paclitaxel 100 mg Injection is used under the supervision of qualified healthcare professionals for the treatment of certain cancers. Depending on the approved indication and treatment protocol, paclitaxel may be used in the management of conditions such as:
- Ovarian cancer
- Breast cancer
- Non-small cell lung cancer
- Certain advanced or metastatic cancers
- Other malignancies where paclitaxel is included in an established chemotherapy regimen
The appropriate dosage, administration schedule, treatment duration, and combination with other medicines depend on the patient’s condition, cancer type, treatment protocol, and healthcare professional’s assessment. It should only be administered by trained medical personnel.
Paclitaxel 100 mg Injection Side Effects
Paclitaxel treatment may cause side effects, and their severity can vary depending on the treatment regimen and individual patient factors. Commonly reported effects may include:
- Hair loss
- Nausea or vomiting
- Fatigue
- Muscle or joint pain
- Peripheral neuropathy
- Diarrhea
- Mouth sores
- Decreased blood cell counts
- Injection-site reactions
Paclitaxel can also cause serious hypersensitivity reactions and significant changes in blood counts. Patients receiving treatment should be appropriately monitored by healthcare professionals. This information is provided for general pharmaceutical reference and does not replace professional medical advice.
Paclitaxel 100 mg Injection Manufacturer in India
Aliyan Pharmaceuticals is an India-based pharmaceutical manufacturer offering a broad portfolio of generic and specialty formulations, including oncology medicines. The company operates with WHO-GMP and EU-GMP certified manufacturing capabilities and supports pharmaceutical businesses seeking dependable manufacturing and sourcing solutions.
For organizations searching for a Paclitaxel 100 mg Injection manufacturer in India, Aliyan Pharmaceuticals provides manufacturing support focused on consistent product quality, controlled production processes, appropriate packaging, and supply coordination. Its oncology portfolio enables distributors, importers, healthcare suppliers, and pharmaceutical companies to source specialized formulations from an experienced Indian manufacturing partner.
The company also supports Paclitaxel 100 mg Injection contract manufacturing and third-party manufacturing requirements, subject to product availability, regulatory requirements, and commercial specifications.
Your Trusted Global Supply Partner
Aliyan Pharmaceuticals supports international pharmaceutical procurement through structured manufacturing and supply services. With a portfolio of 2,500+ pharmaceutical products, the company serves diverse therapeutic requirements and works with business partners across international markets.
Its capabilities are designed to support customers seeking paclitaxel 100 mg injection suppliers in India, bulk pharmaceutical sourcing, and customized third-party manufacturing arrangements. The company emphasizes quality-focused production, reliable coordination, documentation support, and professional communication throughout the supply process.
Expanding Global Reach Through Pharmaceutical Exports
As an India-based pharmaceutical exporter, Aliyan Pharmaceuticals supports the international distribution of generic and specialty medicines across Africa, the Middle East, Latin America, CIS, and other global markets.
For international buyers looking for Paclitaxel 100 mg Injection exporters in India, the company can support export-oriented supply requirements with appropriate product documentation and market-specific coordination. Its experience in pharmaceutical exports helps facilitate communication between manufacturers, importers, distributors, and other healthcare supply partners.
Aliyan Pharmaceuticals also provides access to a wider range of oncology and therapeutic formulations, allowing international buyers to coordinate multiple pharmaceutical requirements through one manufacturing and export partner.
Building Long-Term Partnerships Through Third-Party Manufacturing
Aliyan Pharmaceuticals provides third-party manufacturing and contract manufacturing solutions for pharmaceutical companies, distributors, and healthcare businesses seeking dependable production support in India.
For businesses searching for a Paclitaxel 100 mg Injection third-party manufacturer, the company can coordinate manufacturing requirements based on product specifications, regulatory considerations, packaging needs, order quantities, and applicable market requirements.
Its manufacturing partnership approach focuses on long-term business relationships supported by consistent communication, quality-oriented processes, and supply planning. Whether the requirement involves paclitaxel 100 mg injection suppliers, paclitaxel 100 mg injection manufacturers, paclitaxel 100 mg injection exporters, or broader oncology product sourcing, Aliyan Pharmaceuticals offers a structured platform for pharmaceutical business collaboration.
